Search research articles
Contact Us
Filters
Showing results (61-70 of 122) with videos related to
Page
of 13
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
August 5, 2024
Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany
Christoph Bidlingmaier, Christine Heller, Florian Langer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 19, 2022
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)
Wolfgang Miesbach, Hermann Eichler, Katharina Holstein, et al.
American Journal of Hematology
|
May 5, 2017
Acquired hemophilia A: Updated review of evidence and treatment guidance
Rebecca Kruse-Jarres, Christine L Kempton, Francesco Baudo, et al.
Annals of Hematology
|
September 25, 2020
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
Alexander Solms, Anita Shah, Erik Berntorp, et al.
Annals of Hematology
|
June 26, 2019
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
Anita Shah, Alexander Solms, Sara Wiegmann, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2026
Transfer of Emicizumab into Breast Milk in Postpartum Acquired Hemophilia A
Simon Alexander Krooss, Tim Halling, Dirk Varnholt, et al.
Plos One
|
October 18, 2024
A transposable element prevents severe hemophilia B and provides insights into the evolution of new- and old world primates
Johannes Kopp, Alice Rovai, Michael Ott, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 12, 2020
Expression of human thrombomodulin on porcine endothelial cells can reduce platelet aggregation but did not reduce activation of complement or endothelium - an experimental study
Wolf Ramackers, Dennis Rataj, Sonja Werwitzke, et al.
Annals of Hematology
|
December 17, 2008
Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland
Andreas Tiede, Angela Huth-Kühne, Johannes Oldenburg, et al.
Research and Practice in Thrombosis and Haemostasis
|
January 9, 2026
Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins
Lara Monica, Olga Oleshko, Lina Aires, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 122) with videos related to
Sort By:
Page
of 13
Research and Practice in Thrombosis and Haemostasis
|
August 5, 2024
Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany
Christoph Bidlingmaier, Christine Heller, Florian Langer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 19, 2022
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)
Wolfgang Miesbach, Hermann Eichler, Katharina Holstein, et al.
American Journal of Hematology
|
May 5, 2017
Acquired hemophilia A: Updated review of evidence and treatment guidance
Rebecca Kruse-Jarres, Christine L Kempton, Francesco Baudo, et al.
Annals of Hematology
|
September 25, 2020
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
Alexander Solms, Anita Shah, Erik Berntorp, et al.
Annals of Hematology
|
June 26, 2019
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
Anita Shah, Alexander Solms, Sara Wiegmann, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2026
Transfer of Emicizumab into Breast Milk in Postpartum Acquired Hemophilia A
Simon Alexander Krooss, Tim Halling, Dirk Varnholt, et al.
Plos One
|
October 18, 2024
A transposable element prevents severe hemophilia B and provides insights into the evolution of new- and old world primates
Johannes Kopp, Alice Rovai, Michael Ott, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 12, 2020
Expression of human thrombomodulin on porcine endothelial cells can reduce platelet aggregation but did not reduce activation of complement or endothelium - an experimental study
Wolf Ramackers, Dennis Rataj, Sonja Werwitzke, et al.
Annals of Hematology
|
December 17, 2008
Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland
Andreas Tiede, Angela Huth-Kühne, Johannes Oldenburg, et al.
Research and Practice in Thrombosis and Haemostasis
|
January 9, 2026
Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins
Lara Monica, Olga Oleshko, Lina Aires, et al.
Page
of 13